undergoes

First AI-generated drug enters human clinical trials, targeting chronic lung disease patients (Article) Insilico Medicine, a leading artificial intelligence (AI) drug discovery company, has announced… Read More »First AI-generated drug undergoes human clinical trials to target patients with chronic lung disease